# Bioequivalence Study of Torrent Pharmaceuticals Ltd's Felodipine Extended-Release Tablets Under Fasting Condition

> **NCT01630655** · PHASE1 · COMPLETED · sponsor: **Torrent Pharmaceuticals Limited**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Torrent's Felodipine Extended-Release Tablets

## Key facts

- **NCT ID:** NCT01630655
- **Lead sponsor:** Torrent Pharmaceuticals Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01630655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01630655, "Bioequivalence Study of Torrent Pharmaceuticals Ltd's Felodipine Extended-Release Tablets Under Fasting Condition". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01630655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*